Trial Profile
Teneligliptin-Glimepiride DDI Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jun 2019
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Teneligliptin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Handok Inc
- 30 Apr 2018 Status changed from not yet recruiting to completed.
- 06 Jan 2017 New trial record